Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-03-25
1994-03-15
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 80, 514 82, 514 85, 514183, 514210, 514211, 514299, 514311, 514326, 514331, 514385, 514377, 514391, 514394, 514461, 514428, 514513, 514545, 514547, 514549, 514561, 514562, 514599, 514609, 514501, 514529, 514530, 514533, 514616, 514563, 544398, 544400, 544232, 546112, 546221, 546 23, 546162, 546227, 546233, 546248, 546276, 548175, 548567, 548568, 548950, 549487, 558391, 558170, 560 9, 560 29, 560 41, 560106, 560107, 560119, 560122, 560125, 560168, 562501, 562504, 562507, 562125, A61K 31495, A61K 31675,
Patent
active
052946169
ABSTRACT:
A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
REFERENCES:
patent: 4004008 (1977-01-01), Makovec et al.
patent: 4122255 (1992-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4622331 (1986-11-01), Jozic
patent: 5030654 (1991-07-01), Barnish
Merck Index, 10th Edition, paragraph 9301, Tiropramide, (1985).
Duggan Mark E.
Egbertson Melissa S.
Halczenko Wasyl
Hartman George D.
Laswell William L.
Matukaitis Paul D.
Merck & Co. , Inc.
Parr Richard S.
Tsang Cecilia
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1536216